Changes in Ownership

Cytek Biosciences, Inc. Filed 2022-02-16 Acc 0001104659-22-024375

Director bought 498,629 shares at an average $14.89 ($7,426,825)

From the SEC's structured data for this filing

Trades in this filing

Insider	Date	Transaction	Shares	Price	Value	Owned after	D/I
RA CAPITAL MANAGEMENT, L.P. Director	2022-02-14	Purchase	+166,229	$14.72	$2,446,924	9,773,257	I
RA CAPITAL MANAGEMENT, L.P. Director	2022-02-15	Purchase	+166,200	$14.99	$2,490,524	9,939,457	I
RA CAPITAL MANAGEMENT, L.P. Director	2022-02-16	Purchase	+166,200	$14.98	$2,489,377	10,105,657	I
Open-market purchases · 498,629 sh · avg $14.89 · $7,426,825